NCT00125060View on ClinicalTrials.gov

Transesophageal Magnetic Resonance Imaging (MRI) in Conjunction With Lipid Lowering Measures

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

August 31, 2000

Study Completion Date

April 30, 2004

Conditions
Heart Diseases
Interventions
DRUG

Simvastatin (20mg versus 80mg/day)

Trial Locations (1)

21287

Johns Hopkins - School of Medicine, Baltimore

All Listed Sponsors
collaborator

Surgi-Vision Inc

INDUSTRY

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT00125060 - Transesophageal Magnetic Resonance Imaging (MRI) in Conjunction With Lipid Lowering Measures | Biotech Hunter | Biotech Hunter